ArticleDiabetes, obesity & metabolism2026
Continuous Glucose Monitoring and Hypoglycaemia Risk During Paediatric DKA Treatment in the PICU: A Retrospective Cohort Study.
Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Continuous Glucose Monitoring and Hypoglycaemia Risk During Paediatric DKA Treatment in the PICU: A Retrospective Cohort Study.Diabetes, obesity & metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypoglycaemia is a frequent complication during diabetic ketoacidosis (DKA) treatment. Continuous glucose monitoring (CGM) provides real-time glucose trend information; however, its clinical utility during paediatric DKA management in the intensive care unit (ICU) remains uncertain. We investigated whether CGM insertion during DKA treatment in the paediatric ICU (PICU) is associated with reduced hypoglycaemia and a lower burden of point-of-care (POC) glucose measurements. MATERIALS AND
methodsWe conducted a retrospective single-centre cohort study of paediatric patients (< 20 years) admitted to the PICU with DKA between December 2013 and December 2025 who received continuous intravenous insulin infusion. Patients were categorised based on CGM insertion during their PICU stay. The primary outcome was hypoglycaemia. Secondary outcomes included frequency of POC glucose measurements, ICU length of stay and time to DKA resolution.
resultsSeventy-three patients were included; 31 (42.5%) underwent CGM insertion. The incidence of hypoglycaemia was significantly lower in the CGM group (glucose < 70 mg/dL: 6.5% vs. 47.6%, p < 0.001; < 60 mg/dL: 0% vs. 21.4%, p = 0.008). In multivariable analysis, CGM insertion was independently associated with lower hypoglycaemia risk (adjusted OR 0.059, 95% CI 0.011-0.323; p = 0.001). The CGM group also had a significantly lower frequency of POC glucose measurements than the control group.
conclusionAmongst paediatric patients with DKA treated in the PICU, CGM insertion was independently associated with reduced hypoglycaemia and a lower POC testing burden. Prospective studies are warranted to determine whether CGM-guided DKA management improves clinical outcomes in critically ill children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.